ALS Antibodies

Santa Cruz Biotechnology features a diverse variety of ALS Antibodies for studying amyotrophic lateral sclerosis (ALS) and its underlying mechanisms. ALS Antibodies support various research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Amyotrophic lateral sclerosis is a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle weakness and atrophy. Understanding the molecular pathways involved in ALS is crucial for developing potential therapeutic strategies. ALS Antibodies from Santa Cruz Biotechnology enable detailed investigation of molecular pathways, supporting research into disease pathology and progression. Researchers can examine specific protein interactions and cellular mechanisms associated with motor neuron degeneration. Advanced imaging techniques combined with ALS Antibodies allow visualization of cellular changes during disease progression. Molecular analysis using ALS Antibodies helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of ALS and developing new treatment approaches.